InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Morris Jeffrey Allen. Officer active across 1 company, notably PROVECTUS BIOPHARMACEUTICALS, INC.. Cumulatively, 2 disclosures have been published. History available since 8 May 2023. The latest transaction was filed on 12 August 2024 (C). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations